We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+6.95%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$65.1B
AUM Growth
+$4.63B
Cap. Flow
+$746M
Cap. Flow %
1.15%
Top 10 Hldgs %
9.56%
Holding
3,794
New
469
Increased
1,367
Reduced
1,237
Closed
370

Top Buys

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$354M
2
WFC icon
Wells Fargo
WFC
+$274M
3
IBM icon
IBM
IBM
+$266M
4
QCOM icon
Qualcomm
QCOM
+$257M
5
MDLZ icon
Mondelez International
MDLZ
+$224M

Sector Composition

Rank Sector Weight
1 Technology 14.31%
2 Healthcare 10.66%
3 Consumer Discretionary 10.29%
4 Communication Services 8.78%
5 Financials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WAC
3376
DELISTED
Walter Investment Mgt Corp
WAC
$39K ﹤0.01%
65,773
-289,436
-81% -$168K
BCIC
3377
BCP Investment Corp
BCIC
$94.6M
$38K ﹤0.01%
1,041
RGLS
3378
DELISTED
Regulus Therapeutics
RGLS
$37K ﹤0.01%
+248
New +$31.2K
TRVN
3379
DELISTED
Trevena, Inc.
TRVN
$33K ﹤0.01%
20
-150
-88% -$236K
WIN
3380
DELISTED
Windstream Holdings Inc
WIN
$33K ﹤0.01%
3,773
-1,836
-33% -$24.3K
ETRM
3381
DELISTED
EnteroMedics Inc.
ETRM
$33K ﹤0.01%
+18,535
New +$54.6K
GERN icon
3382
Geron
GERN
$977M
$32K ﹤0.01%
14,856
-15,865
-52% -$37.4K
SMRT
3383
DELISTED
Stein Mart Inc
SMRT
$30K ﹤0.01%
23,196
-106,112
-82% -$138K
CRHM
3384
DELISTED
CRH Medical Corporation
CRHM
$29K ﹤0.01%
11,300
-88,600
-89% -$272K
HOV icon
3385
Hovnanian Enterprises
HOV
$770M
$25K ﹤0.01%
516
-408
-44% -$21.8K
GST
3386
DELISTED
Gastar Exploration Inc.
GST
$25K ﹤0.01%
28,563
-44,451
-61% -$33.1K
SLS icon
3387
SELLAS Life Sciences
SLS
$3.12B
$6K ﹤0.01%
12
-4
-25% -$2.64K
SDRL
3388
DELISTED
Seadrill Limited Common Stock
SDRL
$4K ﹤0.01%
41
-696
-94% -$60.7K
CYHHZ
3389
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$1K ﹤0.01%
99,900
ACN icon
3390
PUT
Accenture
ACN
$113B
-6,600
Closed -$816K
AGI icon
3391
Alamos Gold
AGI
$15.8B
-135,058
Closed -$961K
AGNC icon
3392
AGNC Investment
AGNC
$12.9B
-14,123
Closed -$301K
AGO icon
3393
CALL
Assured Guaranty
AGO
$3.27B
-56,300
Closed -$2.35M
AGO icon
3394
PUT
Assured Guaranty
AGO
$3.27B
-5,400
Closed -$225K
AIZ icon
3395
Assurant
AIZ
$14B
-2,099
Closed -$218K
AL
3396
DELISTED
Air Lease Corp
AL
-9,269
Closed -$346K
ALB icon
3397
Albemarle
ALB
$16.9B
-26,726
Closed -$3.18M
ALLT icon
3398
Allot
ALLT
$366M
-143,839
Closed -$732K
AN icon
3399
AutoNation
AN
$6.6B
-28,687
Closed -$1.24M
AORT icon
3400
CALL
Artivion
AORT
$1.37B
-13,000
Closed -$259K

Similar funds

David Shaw's Q3 2017 Portfolio in Review

As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
  • David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
  • David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
  • David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
  • David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
  • David Shaw opened 469 new positions and closed 370 in Q3 2017.
  • David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.

Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.